4th Quarter - Report
CHAMBER HILL STRATEGIES for AMAG PHARMACEUTICALS (FORMERLY KNOWN AS LUMARA PHARMACEUTICAL)
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Education and advocacy on oral mucositis.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELLE NAWAR | — |
| MICHAELA SIMS | Legislative Director and Counsel, Sen. Bob Kerrey (D-NE) |
| MARY KATHLEEN ZIRKELBACH | — |
Pharmacy PHA
Implementation issues related to P.L. 113-54, the Drug Quality and Security Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER BELL | Legislative Assistant, Rep. John Thune (R-SD) |
| JENNIFER HIGGINS | — |
| MICHAELA SIMS | Legislative Director and Counsel, Sen. Bob Kerrey (D-NE) |
| MARY KATHLEEN ZIRKELBACH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.